INS and type 2 diabetes mellitus: In patients with type 2 diabetes, both insulin lispro and insulin aspart administered immediately before meals have showed an 18–48% reduction in the rise of the 2-h postprandial glucose relative to human insulin given 30 min before the meal [37,42,43].